Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
October 18, 2021 16:50 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on...
Harvard Bioscience Announces Second Quarter 2021 Financial Results
August 05, 2021 07:00 ET
|
Harvard Bioscience, Inc.
Strong double digit revenue growth, solid margin performance despite global supply chain disruptions Revenue up 25% year-over-year as sales momentum continuesCellular and Molecular (CMT) product...
Harvard Bioscience Schedules Second Quarter 2021 Earnings Conference Call for August 5, 2021 at 8:00 AM ET
July 19, 2021 16:45 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on...
Harvard Bioscience Announces First Quarter 2021 Financial Results
May 06, 2021 07:15 ET
|
Harvard Bioscience, Inc.
Sales effectiveness, pre-clinical product demand and disciplined cost management result in improved revenues and margins Revenue up 14% as sales momentum from Q4’20 continuesPre-clinical product...
Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET
April 19, 2021 16:55 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May...
Harvard Bioscience Announces Fourth Quarter 2020 Financial Results
March 10, 2021 07:00 ET
|
Harvard Bioscience, Inc.
Revenue returns to pre-Covid19 levels on strong CRO/pharma salesOperating margin increased year-over-year on GAAP and an adjusted basisNew debt facility significantly reduces annual interest expense ...
Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
February 18, 2021 17:24 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on...
Harvard Bioscience Announces New Credit Facility
December 22, 2020 18:05 ET
|
Harvard Bioscience, Inc.
Improves liquidity and operating flexibilitySignificantly reduces borrowing costsSupports ongoing transformation to profitable growth platform HOLLISTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) --...
Harvard Bioscience to attend Benchmark’s 9th Annual Discovery One-on-One Conference
November 16, 2020 16:35 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in...
Harvard Bioscience Announces Third Quarter 2020 Financial Results
November 05, 2020 07:00 ET
|
Harvard Bioscience, Inc.
Operating margin up year-over-year on GAAP and adjusted basisRevenue improved sequentially with solid CRO/pharma demand and academic labs reopeningGenerated positive operating cash flow in Q3 with...